“Liquid elbows” due to afatinib administration

“Liquid elbows” due to afatinib administration

Non-small cell lung cancer adenocarcinoma in the past decade has targeted therapies as the cornerstone for therapy. In specific patients with epidermal growth factor receptor mutation have three different therapy approaches with the tyrosine kinase inhibitors: erlotinib, gefitinib and afatinib. Nowa...

Full description

Bibliographic Details
Main Authors: Paul Zarogoulidis, Panos Chinelis, Anastasia Athanasiadou, Konstantinos Porpodis, Anastasios Kallianos, Aggeliki Rapti, Georgia Trakada, Lemonia Velentza, Haidong Huang, Theodora Tsiouda, Wolfgang Hohenforst-Schmidt
Format: Article
Language:English
Published: Elsevier 2017-01-01
Series:Respiratory Medicine Case Reports
Subjects:
Tyrosine kinase inhibitors
Afatinib
Elbow bursitis
Olecranon bursitis
Online Access:http://www.sciencedirect.com/science/article/pii/S2213007117302009

Internet

http://www.sciencedirect.com/science/article/pii/S2213007117302009

Similar Items